好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Amphetamine-Enhanced Stroke Recovery (AESR) Trial: Primary Part 1 Results
Cerebrovascular Disease and Interventional Neurology
(-)
003
Authors/Disclosures
Larry B. Goldstein, MD, FAHA, FAAN (University of Kentucky)
PRESENTER
The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Meheroz H. Rabadi, MD, FAAN (Dept of VA Medical Center #127) No disclosure on file
Michael A. Vogelbaum, MD, PhD, FACS (Cleveland Clinic Lerner College of Med) No disclosure on file
Michael J. Reding, MD No disclosure on file
Laura Lennihan, MD, FAAN (Neurological Institute of New York) No disclosure on file
David C. Good, MD, FAAN Dr. Good has a non-compensated relationship as a President with World Federation for Neurorehabilitation that is relevant to AAN interests or activities.
Alexander W. Dromerick, MD (National Rehabilitation Hospital) No disclosure on file
No disclosure on file
Gregory Samsa No disclosure on file